[144] Blend Labs, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filing for Blend Labs, Inc. (BLND) reports a proposed sale of 25,000 common shares to be executed through Charles Schwab & Co., Inc. on 08/15/2025 with an aggregate market value of $71,873. The shares were acquired on 02/17/2020 via exercise and hold and fully paid in cash.

The filer previously sold a total of 150,000 shares in six transactions between 06/16/2025 and 07/15/2025, generating aggregate gross proceeds of $503,272. The issuer's reported outstanding shares are 255,696,747, and the planned sale is recorded on the NYSE.

Insights

Securities Compliance Analyst

TL;DR: Routine Form 144 notice showing an insider sale following prior transactions; filings appear to document required disclosure.

The Form 144 discloses a proposed sale of 25,000 shares by an individual who previously sold 150,000 shares across six trades in the prior month. The shares were acquired by exercise on 02/17/2020 and the planned sale is routed through a registered broker-dealer. From a compliance perspective, the filing contains the expected elements: acquisition date and method, broker, share counts, and gross market values. There is no indication in the document of undisclosed material nonpublic information or of any irregularities in reporting. Impact on investors depends on context not provided in this filing.

Equity Analyst

TL;DR: Insider disposition disclosed; economic significance is small relative to total shares outstanding.

The notice shows cumulative insider sales of 150,000 shares totaling $503,272 and a separate proposed sale of 25,000 shares valued at $71,873. Against the issuer's stated 255.7 million shares outstanding, these transactions represent a de minimis share percentage and are unlikely to meaningfully affect liquidity or valuation on their own. The filing does not include trading motivation or any change in insider ownership concentration, so material investor implications are limited based on this document alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	25000	71873.00	255696747	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2020	Exercise and Hold	BLEND LABS, INC.			25000	02/17/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	06/16/2025	45000	145268.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	06/23/2025	20000	63315.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	06/30/2025	20000	66240.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/07/2025	20000	69182.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/14/2025	20000	68438.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/15/2025	25000	90829.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for BLND disclose?

The filing discloses a proposed sale of 25,000 common shares through Charles Schwab on 08/15/2025 with an aggregate market value of $71,873.

How were the 25,000 shares acquired?

They were acquired on 02/17/2020 by exercise and hold and paid for in cash according to the filing.

Has the filer sold other BLND shares recently?

Yes. The filer sold a total of 150,000 shares in six transactions between 06/16/2025 and 07/15/2025, with aggregate gross proceeds of $503,272.

Through which broker will the proposed sale occur?

The proposed sale is to be executed through Charles Schwab & Co., Inc. (address listed in the filing).

How large is the proposed sale relative to total shares outstanding?

The issuer's outstanding shares are reported as 255,696,747; the proposed sale of 25,000 shares is a very small fraction of that total.